Aim. To determine the difference in hospital outcomes between percutaneous coronary intervention (PCI) and conservative treatment of elderly female patients hospitalized for acute coronary syndrome (ACS).
INTRODUCTION
Cardiovascular diseases and especially acute coronary syndrome (ACS) are the leading cause of death in industrialized countries with an incidence of 3 per 1000 inhabitants, and by 2020, are very likely to be so in developing countries as well. (1) Distinguishing patients with ACS among those that present with suspected cardiac pain is a diagnostic challenge, especially in individuals without clear symptoms or electrocardiographic features. Despite modern treatment, mortality and readmission of patients with ACS remains high.
(2) With diagnostic advances and treatment of ACS, mortality in men has been reduced over the past decade; however, mortality in women has been increasing since 1984. (3) Previous studies have also shown that women and elderly with ACS are less likely to undergo diagnostic and therapeutic procedures than men. (4) (5) (6) (7) (8) (9) (10) Underestimation of risk by the treating physician and atypical presentation could be behind these findings, as well as the presumed increased risks of invasive treatment in women. (11, 12) The main reason why physicians choose conservative therapy over percutaneous coronary intervention (PCI) in the elderly is because they are concerned about the complications of an invasive approach in these patients. (13) Recent guidelines from the European Society of Cardiology suggest that age and sex should not be a criterion for conservative therapy because older people and women generally have better outcomes after prompt invasive treatments. (2) Recent studies also show benefits 1 and 5 years after PCI treatment in these patients. (14, 15) Limited data, however, exist on in-hospital benefits of invasive therapy, especially in high risk groups. Because elderly female patients with ACS have the least chance of receiving invasive treatment, we wanted to determine whether there is a difference in hospital outcomes between conservative and invasive therapy in these patients.
MATERIAL AND METHODS

Study population
This retrospective, historical, controlled study included data from 123 postmeno- 
Data collection
Trained research assistants collected demographic data (age, height and weight), socioeconomic status, date of admission, diagnosis on admission, symptoms on admission, physical examination findings on admission, duration of hospitalization, previously diagnosed illnesses, lifestyle habits, marital status, blood test results during hospitalization, clinical examination findings during hospitalization and drugs used before and during hospitalization.
The participants were identified as either suffering from diabetes mellitus or not. Arterial hypertension and year of diagnosis was categorized as previously diagnosed or previous use of antihypertensive drugs. The subjects were identified as either suffering from arterial hypertension or not. In patients with a diagnosis of arterial hypertension we also wrote the year when the arterial hypertension was diagnosed for the first time. Cigarette smoking was categorized as non-smokers or smokers, if they were smoking or had ever smoked. Dyslipidemia was diagnosed as an elevation of total cholesterol (>4.5mmol/L), low-density lipoprotein (LDL) cholesterol (>2.3 mmol/L) and triglyceride (TG) concentrations (>1.8mmol/L), and by a decrease in high-density lipoprotein (HDL) cholesterol concentration in the blood (<0.9 mmol/L). The subjects were identified as either having dyslipidemia or not. History of coronary artery bypass graft (CABG), ischemic heart disease, cerebrovascular insult, peripheral artery disease, myocardial infarction and PCI were characterized as procedures or diagnoses that the participant had had until the present.
Heart failure was classified using the Killip classification (18) as Killip class 3 or 4 and using the New York Heart Association functional classification (NYHA) (19) as NYHA class 3 or 4. Complications during hospitalization were described as complications that can occur after treatment, modeled by recent guidelines. (2) Heart failure, death and arrhythmias, that can occur as complications of some treatments, were observed separately. Arrhythmia was classified as an abnormal heart rhythm: premature atrial and ventricular contractions, supraventricular tachycardias, ventricular arrhythmias and bradyarrhythmias. Arrhythmia, ST elevation, ST depression, T waves and Q waves were diagnosed with the electrocardiograph model ECG-9620M (Nihon Kohden Corporation, Tokyo, Japan). Heart failure, LVEDD and LVEF were diagnosed with a Nemio SSA-550A ultrasound (Toshiba Corporation, Shimoishigami, Japan).
Laboratory Measurements
Morning blood was collected after 12-hours of fasting and after a 20-minute morning rest. The following parameters were obtained: total cholesterol, LDL, HDL, TG and serum glucose by standard enzymatic methods on an Olympus AU-640 (Olympus, Tokyo, Japan). LDL-C was calculated using Friedwald equation. If TG concentration was above 3 mmol/L, HDL-C and LDL-C were measured by direct immunoinhibition method (Olympus Diagnostica, Lismeehan, Ireland) and homogeneous assay (Randox Laboratories, Crumlin, United Kingdom), respectively.
Statistical analysis
Data analysis was performed using the Statistica 10 software package (StatSoft Inc., Tulsa, OK, USA). Categorical variables were expressed as frequencies and percentages. A chi-square test was used to establish the relationship between pairs of categorical variables. Continuous variables were expressed as mean and standard deviation (M±SD) whereas t-test for independent samples was used to check for statistical significance. The statistical significance level was set at 95% (p<0.05).
RESULTS
One hundred twenty three female patients participated in the study, with a mean age of 71 ± 8.7 of those treated conservatively and 65 ± 8.8 of those treated with PCI (P<0.001, table 1). There was no significant difference in their body mass index (BMI), systolic blood pressure or diastolic blood pressure, however among those treated with conservative therapy there was significantly less retirees than among those treated with PCI (n=9; 12.86% vs n=26; 52%, P<0.001). In the conservative group, the most common symptoms on admission were chest pain (n=41; 58.57% vs n=33; 62.26%, P<0.001) and dyspnea (n=28; 40% vs n=7; 13.21%, P<0.001). In the conservative group there were more patients who smoked (n=13; 25% vs n=7; 10%, P=0.031) and who had dyslipidemia (n=33; 62% vs n=26; 37%, P=0.006, table 1). Of the laboratory parameters, only triglycerides were significantly higher in participants treated with conservative therapy (2.21 ± 1.06) compared to those treated with PCI (1.66 ± 0.72, P=0.009, table 2). There were no statistical differences between heart failure (n=31; 44.28% vs n=28; 52.83%, P=0.233, table 3) and death (n=2; 2.86% vs n=1; 1.89%, P=0.73) during admission among the groups, however more arrhythmias were detected in the conservative group (n=29, 41.43% vs n=3, 5.66%, P<0.001) and less ST elevations (n=0; 0% vs n=9, 16.98%, P<0.001). Furthermore, during hospitalization there were significantly more cases of heart failure among those treated with conservative therapy (n=20; 27.4%) compared to those treated with PCI (n=3; 5.66%, P=0.001, table 3). No differences were observed in complications that occurred during hospitalization between the groups. BMI, body mass index; BP, blood pressure; CABG, coronary artery bypass graft; M±SD, arithmetic mean ± standard deviation; P, significance level; *, P<0.05; PCI, percutaneous coronary intervention. CK, creatinine kinase; CKMB, creatinine kinase myoglobin; HDL, high density lipoproteins; LDL, low density lipoproteins; M±SD, arithmetic mean ± standard deviation; P, significance level; *, P<0.05; PCI, percutaneous coronary intervention. 
DISCUSSION
Women with ACS are more likely to be treated with conservative therapy than men. (4-10) Also, because of possible complication associated with the invasive approach, elderly are less often treated with PCI. (13) Although recent guidelines suggest that women and the elderly have better outcomes after prompt invasive treatments, they are often treated with conservative therapy. (2) Because elderly female patients with ACS have the least chance of getting PCI, we wanted to determine whether there is a difference in hospital outcomes between conservative and PCI in these patients.
In our study, chest pain was present in 59% of patients on admission. This atypical presentation of patients with ACS has been well documented, especially in the elderly and women. (2) Although patients treated with PCI had more serious presenting symptoms and higher ST elevation during hospitalization, they had better treatment outcomes compared to patients treated with conservative therapy: including less infarctions and less arrhythmias. There was no significant difference in complications during hospitalization after treatment when we compared these two groups, although there were slightly more complications compared to other studies. (20) The reason for this is most likely the higher age of our study groups.
Our study has several limitations. We collected data on patients admitted to only one hospital in 2007 and 2011, and only for several months. The reason we chose 2011 was because that was the first year we had complete data sets of PCI treated patients in those selected months. Another limitation is that we did not analyze the drugs that patients were given during hospitalization, only the type of treatment. Further studies should report on long term effects and include more patients when comparing conservative and PCI in elderly women.
Conclusion of this retrospective study is that elderly female patients presenting with ACS and treated with PCI had significantly less arrhythmias and episodes of heart failure during hospitalization when compared to patients treated with conservative treatment. These results suggest that even high risk patients have better outcomes after treatment with PCI, strengthening PCI as the suggested first-line treatment for ACS, regardless of associated risk factors.
